Mp26-05 Effect of Antihistamine on Ureteral Stent-Related Symptoms: A Double-Blind Randomized Controlled Trial

You have accessJournal of UrologyStone Disease: Medical Figure 1); moreover, there were no differences between arms in any USSQ domain (p>0.05). There were no differences between study and control groups in mean duration of narcotic analgesia use (0.05 vs. 0.13 day, p=0.21), mean number of office phone calls for urinary symptoms (0.15 vs. 0.24, p=0.45), or absolute number of Emergency Department visits in each cohort (3 vs. 3, p=1.00). No patient experienced adverse drug events (e.g., urinary retention) or post-operative complications. CONCLUSIONS: Post-operative antihistamines were well-tolerated but did not significantly reduce ureteral stent-related symptoms. Download PPT Source of Funding: Coloplast – investigator-initiated trial © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e415 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information David S. Han More articles by this author Ezra J. Margolin More articles by this author Miyad Movassaghi More articles by this author Jeffrey P. Johnson More articles by this author Mahveesh Chowdhury More articles by this author Srinath-Reddi Pingle More articles by this author Ron Golon More articles by this author Michael L. Schulster More articles by this author David M. Weiner More articles by this author Ojas Shah More articles by this author Expand All Advertisement PDF downloadLoading ...